Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Medicine Reports

• Publication date

  2015-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3892/mmr.2015.3695PMID 25936382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension

  2013cited by this paper
• Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats.

  2012cited by this paper
• Inflammation in pulmonary arterial hypertension.

  2012cited by this paper
• Erythropoietin, but Not Asialoerythropoietin or Carbamyl-Erythropoietin, Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats

  2012cited by this paper
• Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary Hypertension

  2011cited by this paper
• Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Increases Lung Inflammation and Activates Pulmonary Microvascular Endothelial Cells via an IL-4–Dependent Mechanism

  2010cited by this paper
• [Genetic, cellular and molecular mechanisms of pulmonary arterial hypertension].

  2010cited by this paper
• Idiopathic pulmonary arterial hypertension

  2010cited by this paper
• Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.

  2010cited by this paper
• Inflammatory cytokines in vascular dysfunction and vascular disease.

  2009cited by this paper
• Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice

  2009cited by this paper
• Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.

  2009cited by this paper
• K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.

  2009cited by this paper
• Resveratrol Prevents Monocrotaline‐induced Pulmonary Hypertension in Rats

  2008cited by this paper
• Adeno‐associated virus vector‐mediated systemic interleukin‐10 expression ameliorates hypertensive organ damage in Dahl salt‐sensitive rats

  2008cited by this paper
• Endothelial dysfunction in heart failure.

  2008cited by this paper
• Iptakalim Alleviates Rotenone-Induced Degeneration of Dopaminergic Neurons through Inhibiting Microglia-Mediated Neuroinflammation

  2007cited by this paper
• Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

  2007cited by this paper
• PECAM-1: a multi-functional molecule in inflammation and vascular biology.

  2007cited by this paper
• The importance of endothelin-1 for vascular dysfunction in cardiovascular disease.

  2007cited by this paper
• The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis.

  2007cited by this paper
• A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells.

  2007cited by this paper
• Treatment of pulmonary arterial hypertension.

  2006cited by this paper
• Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells.

  2006cited by this paper
• Loss of PECAM-1 Function Impairs Alveolarization*

  2006cited by this paper
• Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway.

  2005cited by this paper
• ZAPRINAST ATTENUATES HYPOXIC PULMONARY ARTERY INJURY AND CAUSES LESS AORTIC RELAXATION THAN MILRINONE

  2005cited by this paper
• Effects of iptakalim hydrochloride, a novel KATP channel opener, on pulmonary vascular remodeling in hypoxic rats.

  2004cited by this paper
• Treatment of pulmonary arterial hypertension.

  2004cited by this paper
• IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo.

  2004cited by this paper
• Pathology of pulmonary hypertension.

  2004cited by this paper
• Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.

  2003cited by this paper
• Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride, and its molecular mechanisms

  2003cited by this paper
• Inflammatory cytokines and cardiovascular disease.

  2003cited by this paper
• Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.

  2002cited by this paper
• Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

  2000cited by this paper
• eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow.

  1998cited by this paper
• The biology of PECAM-1.

  1997cited by this paper
• The biology of PECAM-1.

  1997cited by this paper
• Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

  1995cited by this paper
• ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells.

  1993cited by this paper
• Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features.

  1979cited by this paper

• The Sigma-1 receptor agonist PRE084 improves cardiopulmonary function and remodelling in an experimental model of pulmonary arterial hypertension.

  2026cites this paper
• Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension

  2023cites this paper
• Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension

  2022cites this paper
• The expression of ATP-sensitive potassium channels in human umbilical arteries with severe pre-eclampsia

  2021cites this paper
• The mechanism of ions in pulmonary hypertension

  2021cites this paper
• Cardiac energetics alteration in chronic hypoxia rat model: a non invasive in vivo 31P magnetic resonance spectroscopy experimental study

  2021cites this paper
• Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells.

  2021cites this paper
• Cardiac energetics alteration in a chronic hypoxia rat model: A non-invasive in vivo31P magnetic resonance spectroscopy study

  2021cites this paper
• Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension

  2020cites this paper
• Nicorandil Attenuates LPS-Induced Acute Lung Injury by Pulmonary Endothelial Cell Protection via NF-κB and MAPK Pathways

  2019cites this paper
• Iptakalim ameliorates hypoxia-impaired human endothelial colony-forming cells proliferation, migration, and angiogenesis via Akt/eNOS pathways

  2019cites this paper
• Effects of Qibaipingfei capsules on pulmonary vascular relaxation through KATP channel activation by the NO/cGMP signaling pathway.

  2018cites this paper
• Analysis for Carom complex, signaling and function by database mining.

  2016cites this paper
• Alveolar Hypoxia-Induced Pulmonary Inflammation: From Local Initiation to Secondary Promotion by Activated Systemic Inflammation

  2016cites this paper